the
diagnostic and therapeutic potential of miRNA methylation, we seek to highlight its value in enhancing
Sufianov, A.,
Kostin, A.,
Begliarzade, S.,
Kudriashov, V.,
Ilyasova, T.,
Liang, Y.,
Mukhamedzyanov, A.,
Beylerli, O. (2023) diagnostic and therapeutic strategies. Molecular genetic aspects of the etiology and pathogenesis of diabetes
GAREEV, I.,
YANG, G.,
SUN, J.,
BEYLERLI, O.,
CHEN, X.,
ZHANG, D.,
ZHAO, B.,
ZHANG, R.,
SUN, Z.,
YANG, Q.,
LI, L.,
ZHAO, S.,
PAVLOV, V.,
SAFIN, S. (2020) biomarkers for the diagnosis of ICH.
Methods: The plasma samples from 106 patients with ICH and 50 patients
Beylerli, O.,
Khasanov, D.,
Gareev, I.,
Valitov, E.,
Sokhatskii, A.,
Wang, C.,
Pavlov, V.,
Khasanova, G.,
Ahmad, A. (2021) transcription polymerase chain reaction (qRT-PCR) analyses of tumor tissue and plasma.
Methods: Plasma and PA
Fedorova, Yu. Yu.,
Aminova, E.T.,
Faishanova, R.R.,
Zagitov, I.R.,
Romanova, A.R.,
Nurgalieva, A.Kh.,
Andreeva, E.A.,
Darvish, M.,
Khusnutdinova, E.K.,
Prokofyeva, D.S. (2025) and epigenetic disorders. MicroRNAs are currently considered one of the most promising prognostic and
diagnostic